Document is current
Any future updates will be listed below
-
Authors
Bregón-Villahoz, Marta https://orcid.org/0000-0003-2196-272X
Díez, Ander https://orcid.org/0000-0002-3250-4962
Galech, Jon
Cuétara, Maria-Soledad
Carrano, Giulia https://orcid.org/0000-0002-3117-7517
Moragues, Maria-Dolores https://orcid.org/0000-0002-7272-8610
Fernandez-de-Larrinoa, Iñigo https://orcid.org/0000-0001-6326-2487
Arrieta-Aguirre, Inés https://orcid.org/0000-0002-2593-2221
-
Funding
Funding for this research was provided by:
Euskal Herriko Unibertsitatea (GIU21/017, PIF19/316)
Hezkuntza, Hizkuntza Politika Eta Kultura Saila, Eusko Jaurlaritza (IT913-16)
Universidad del País Vasco
- License Information
-
More Information
Article History
Received: 14 July 2025
Accepted: 6 November 2025
First Online: 14 November 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The generation of genetically modified organisms to express recombinant proteins and test their usefulness in the diagnosis of invasive candidiasis was approved by the Ethics Commission of the University of the Basque Country EHU (M30_2021_145). Human sera used in this study were collected prospectively and are part of an anonymised sera collection registered at the Instituto de Salud Carlos III (C.0005025) and its use is authorised by the University of the Basque Country EHU (CEISH/216RM/2013).
